ETF Managers Group, LLC Gritstone Bio, Inc. Transaction History
ETF Managers Group, LLC
- $2.78 Billion
- Q1 2023
A detailed history of ETF Managers Group, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 27,912 shares of GRTS stock, worth $17,305. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,912
Previous 20,784
34.3%
Holding current value
$17,305
Previous $71,000
8.45%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GRTS
# of Institutions
98Shares Held
45.6MCall Options Held
861KPut Options Held
4.52M-
Morgan Stanley New York, NY6.74MShares$4.18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.79MShares$3.59 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.76MShares$3.57 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$2.93 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA3.56MShares$2.21 Million12.76% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $45.3M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...